Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 518Breast Neoplasms 456Lung Neoplasms 252Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 185Pancreatic Neoplasms 154Carcinoma, Hepatocellular 136Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Melanoma 93Head and Neck Neoplasms 93Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 85Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 75Liver Neoplasms 74Hematologic Neoplasms 74Endometrial Neoplasms 71Leukemia, Myeloid, Acute 66Neoplasm Metastasis 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Sarcoma 53Leukemia 53Glioma 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × Hepatocellular Carcinoma Resectable × Clear all
NCT06157060 2026-03-20

Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

Zhujiang Hospital

Recruiting
255 enrolled
Gastrointestinal

Hepatocellular Carcinoma Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡